(AROW) Arrow Financial - Overview
Stock: Deposits, Loans, Trust, Insurance, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.11% |
| Yield on Cost 5y | 4.86% |
| Yield CAGR 5y | 4.42% |
| Payout Consistency | 93.6% |
| Payout Ratio | 42.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.7% |
| Relative Tail Risk | -8.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 23.00 |
| Character TTM | |
|---|---|
| Beta | 0.681 |
| Beta Downside | 0.757 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.18% |
| CAGR/Max DD | 0.24 |
Description: AROW Arrow Financial December 27, 2025
Arrow Financial Corporation (NASDAQ:AROW) is a New York-based bank holding company that offers a full suite of commercial and consumer banking services across the United States, including demand and interest-bearing deposits, a broad array of loan products (commercial, CRE, consumer installment, auto, and residential), and ancillary wealth-management and insurance services.
Key operating metrics from the most recent quarter (Q3 2024) show a net interest margin of approximately 3.2%, a loan-to-deposit ratio of 73%, and a Common Equity Tier 1 (CET1) capital ratio of 12.5%, indicating solid liquidity and capital adequacy relative to regional-bank peers.
Sector-level drivers that materially affect Arrow’s performance are the Federal Reserve’s interest-rate policy (which sets the spread between loan yields and deposit costs) and the ongoing stress in commercial-real-estate (CRE) markets that can pressure loan-loss provisions for regional banks with sizable CRE exposure.
In Q3 2024 the company reported revenue of $140 million and earnings per share of $0.68, with a market capitalization near $1.2 billion; its balance sheet includes an indirect lending program that diversifies credit risk across third-party originators.
For a deeper quantitative dive, the ValueRay AROW dashboard provides granular historical data and scenario analytics that can help you assess the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 44.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.62 > 1.0 |
| NWC/Revenue: -285.8% < 20% (prev -1439 %; Δ 1153 % < -1%) |
| CFO/TA 0.01 > 3% & CFO 41.0m > Net Income 44.0m |
| Net Debt (62.0k) to EBITDA (59.5m): 0.00 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.4m) vs 12m ago -1.95% < -2% |
| Gross Margin: 65.27% > 18% (prev 0.60%; Δ 6466 % > 0.5%) |
| Asset Turnover: 5.54% > 50% (prev 5.18%; Δ 0.36% > 0%) |
| Interest Coverage Ratio: 0.50 > 6 (EBITDA TTM 59.5m / Interest Expense TTM 77.0m) |
Altman Z'' -0.86
| A: -0.16 (Total Current Assets 29.1m - Total Current Liabilities 722.4m) / Total Assets 4.45b |
| B: 0.02 (Retained Earnings 102.3m / Total Assets 4.45b) |
| C: 0.01 (EBIT TTM 38.6m / Avg Total Assets 4.38b) |
| D: 0.03 (Book Value of Equity 120.3m / Total Liabilities 4.01b) |
| Altman-Z'' Score: -0.86 = CCC |
What is the price of AROW shares?
Over the past week, the price has changed by +2.95%, over one month by +10.27%, over three months by +18.56% and over the past year by +38.52%.
Is AROW a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AROW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.5 | -3.2% |
| Analysts Target Price | 34.5 | -3.2% |
| ValueRay Target Price | 39.3 | 10.1% |
AROW Fundamental Data Overview February 09, 2026
P/S = 3.7446
P/B = 1.3728
P/EG = 2.41
Revenue TTM = 242.6m USD
EBIT TTM = 38.6m USD
EBITDA TTM = 59.5m USD
Long Term Debt = 24.3m USD (from longTermDebt, two quarters ago)
Short Term Debt = 971.0k USD (from shortTermDebt, two quarters ago)
Debt = 29.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 62.0k USD (from netDebt column, last quarter)
Enterprise Value = 592.9m USD (592.9m + Debt 29.2m - CCE 29.1m)
Interest Coverage Ratio = 0.50 (Ebit TTM 38.6m / Interest Expense TTM 77.0m)
EV/FCF = 16.72x (Enterprise Value 592.9m / FCF TTM 35.5m)
FCF Yield = 5.98% (FCF TTM 35.5m / Enterprise Value 592.9m)
FCF Margin = 14.62% (FCF TTM 35.5m / Revenue TTM 242.6m)
Net Margin = 18.12% (Net Income TTM 44.0m / Revenue TTM 242.6m)
Gross Margin = 65.27% ((Revenue TTM 242.6m - Cost of Revenue TTM 84.3m) / Revenue TTM)
Gross Margin QoQ = 67.69% (prev 67.45%)
Tobins Q-Ratio = 0.13 (Enterprise Value 592.9m / Total Assets 4.45b)
Interest Expense / Debt = 66.68% (Interest Expense 19.5m / Debt 29.2m)
Taxrate = 16.40% (2.75m / 16.8m)
NOPAT = 32.3m (EBIT 38.6m * (1 - 16.40%))
Current Ratio = 0.04 (Total Current Assets 29.1m / Total Current Liabilities 722.4m)
Debt / Equity = 0.07 (Debt 29.2m / totalStockholderEquity, last quarter 431.9m)
Debt / EBITDA = 0.00 (Net Debt 62.0k / EBITDA 59.5m)
Debt / FCF = 0.00 (Net Debt 62.0k / FCF TTM 35.5m)
Total Stockholder Equity = 415.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.00% (Net Income 44.0m / Total Assets 4.45b)
RoE = 10.58% (Net Income TTM 44.0m / Total Stockholder Equity 415.6m)
RoCE = 8.78% (EBIT 38.6m / Capital Employed (Equity 415.6m + L.T.Debt 24.3m))
RoIC = 7.38% (NOPAT 32.3m / Invested Capital 437.4m)
WACC = 8.02% (E(592.9m)/V(622.0m) * Re(8.42%) + (debt cost/tax rate unavailable))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.75%
[DCF Debug] Terminal Value 75.04% ; FCFF base≈24.4m ; Y1≈20.4m ; Y5≈15.0m
Fair Price DCF = 16.60 (EV 273.1m - Net Debt 62.0k = Equity 273.0m / Shares 16.4m; r=8.02% [WACC]; 5y FCF grow -19.99% → 2.90% )
EPS Correlation: -8.83 | EPS CAGR: 3.03% | SUE: 1.82 | # QB: 3
Revenue Correlation: 91.83 | Revenue CAGR: 15.10% | SUE: 3.29 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=3.45 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+25.8% | Growth Revenue=+10.2%
EPS next Year (2027-12-31): EPS=3.65 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+5.8% | Growth Revenue=+5.2%